Arterial  	Arterial  	 JJ	B-NP
stiffness  	stiffness  	 NN	I-NP
and  	and  	 CC	O
proinflammatory  	proinflammatory  	 JJ	B-NP
cytokines  	cytokines  	 NN	I-NP
in  	in  	 IN	O
fibromyalgia  	fibromyalgia  	 JJ	B-NP
syndrome  	syndrome  	 NN	I-NP
We  	We  	 PRP	O
assessed  	assessed  	 VBD	O
arterial  	arterial  	 JJ	B-NP
stiffness  	stiffness  	 NN	I-NP
and  	and  	 CC	O
inflammatory  	inflammatory  	 JJ	B-NP
cytokine  	cytokine  	 JJ	I-NP
profiles  	profiles  	 NNS	I-NP
in  	in  	 IN	O
fibromyalgia  	fibromyalgia  	 JJ	B-NP
syndrome  	syndrome  	 NN	I-NP
( 	( 	 -LRB-	O
FMS 	FMS 	 NNP	B-NP
)  	)  	 -RRB-	O
patients  	patients  	 NNS	O
and  	and  	 CC	O
analysed  	analysed  	 VBG	O
the  	the  	 DT	O
association  	association  	 NN	O
between  	between  	 IN	O
them 	them 	 PRP	O
.  	.  	 .	O
Twenty-seven  	Twenty-seven  	 NNP	O
FMS  	FMS  	 NNP	B-NP
patients  	patients  	 NNS	O
and  	and  	 CC	O
29  	29  	 CD	O
age-matched  	age-matched  	 JJ	O
premenopausal  	premenopausal  	 JJ	B-NP
healthy  	healthy  	 JJ	I-NP
controls  	controls  	 NNS	I-NP
were  	were  	 VBD	O
enrolled  	enrolled  	 VBN	O
in  	in  	 IN	O
this  	this  	 DT	O
study 	study 	 NN	O
.  	.  	 .	O
Arterial  	Arterial  	 JJ	B-NP
stiffness  	stiffness  	 NN	I-NP
was  	was  	 VBD	O
assessed  	assessed  	 VBN	O
by  	by  	 IN	O
pulse  	pulse  	 JJ	B-NP
wave  	wave  	 NN	I-NP
velocity  	velocity  	 NN	I-NP
( 	( 	 -LRB-	O
PWV 	PWV 	 NNP	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
augmentation  	augmentation  	 JJ	B-NP
index  	index  	 NN	I-NP
( 	( 	 -LRB-	O
AIx 	AIx 	 NNP	B-NP
)  	)  	 -RRB-	O
from  	from  	 IN	O
pulse  	pulse  	 JJ	O
waveform  	waveform  	 JJ	B-NP
analysis 	analysis 	 NN	I-NP
.  	.  	 .	O
Levels  	Levels  	 NNS	O
of  	of  	 IN	O
serum  	serum  	 CD	B-NP
interleukin-1β  	interleukin-1β  	 CD	I-NP
( 	( 	 -LRB-	O
IL-1β 	IL-1β 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
IL-6 	IL-6 	 NNP	B-NP
,  	,  	 ,	O
IL-8 	IL-8 	 NNP	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
vascular  	vascular  	 JJ	B-NP
endothelial  	endothelial  	 JJ	I-NP
growth  	growth  	 NN	I-NP
factor  	factor  	 NN	I-NP
( 	( 	 -LRB-	O
VEGF 	VEGF 	 NNP	B-NP
)  	)  	 -RRB-	O
were  	were  	 VBD	O
measured  	measured  	 VBN	O
by  	by  	 IN	O
enzyme-linked  	enzyme-linked  	 JJ	O
immunosorbent  	immunosorbent  	 JJ	B-NP
assay 	assay 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
a  	a  	 DT	O
colorimetric  	colorimetric  	 JJ	B-NP
assay  	assay  	 NN	I-NP
was  	was  	 VBD	O
used  	used  	 VBN	O
for  	for  	 IN	O
measurement  	measurement  	 NN	O
of  	of  	 IN	O
serum  	serum  	 FW	B-NP
nitric  	nitric  	 FW	I-NP
oxide  	oxide  	 FW	I-NP
( 	( 	 -LRB-	O
NO 	NO 	 UH	B-NP
)  	)  	 -RRB-	O
metabolites  	metabolites  	 NNS	B-NP
( 	( 	 -LRB-	O
nitrate  	nitrate  	 NN	B-NP
and  	and  	 CC	O
nitrite 	nitrite 	 NN	B-NP
,  	,  	 ,	O
NOx 	NOx 	 NNP	B-NP
)  	)  	 -RRB-	O
level 	level 	 NN	O
.  	.  	 .	O
Statistical  	Statistical  	 JJ	B-NP
analyses  	analyses  	 NNS	I-NP
included  	included  	 VBD	O
the  	the  	 DT	O
Mann-Whitney  	Mann-Whitney  	 JJ	B-NP
U-test  	U-test  	 JJ	I-NP
and  	and  	 CC	O
Spearman 	Spearman 	 NNP	O
's  	's  	 POS	O
correlation  	correlation  	 JJ	B-NP
coefficient  	coefficient  	 JJ	I-NP
analysis 	analysis 	 NN	I-NP
.  	.  	 .	O
Higher  	Higher  	 RBR	O
AIx  	AIx  	 JJ	O
and  	and  	 CC	O
AIx 	AIx 	 JJ	O
@ 	@ 	 IN	O
HR75  	HR75  	 NNP	B-NP
( 	( 	 -LRB-	O
aortic  	aortic  	 JJ	B-NP
AIx  	AIx  	 NN	I-NP
at  	at  	 IN	O
a  	a  	 DT	O
heart  	heart  	 NN	B-NP
rate  	rate  	 NN	I-NP
of  	of  	 IN	O
75  	75  	 CD	O
beats 	beats 	 CD	B-NP
/ 	/ 	 CD	I-NP
min 	min 	 CD	I-NP
)  	)  	 -RRB-	O
were  	were  	 VBD	O
noted  	noted  	 VBN	O
in  	in  	 IN	O
FMS  	FMS  	 NNP	B-NP
compared  	compared  	 VBN	O
to  	to  	 TO	O
those  	those  	 DT	O
in  	in  	 IN	O
the  	the  	 DT	O
controls  	controls  	 NNS	O
after  	after  	 IN	O
adjustment  	adjustment  	 NN	O
using  	using  	 VBG	O
covariants  	covariants  	 NNS	B-NP
( 	( 	 -LRB-	O
p 	p 	 FW	B-NP
( 	( 	 -LRB-	I-NP
adj 	adj 	 LS	I-NP
) 	) 	 -RRB-	O
=0.023  	=0.023  	 NNP	O
and  	and  	 CC	O
p 	p 	 NNS	B-NP
( 	( 	 -LRB-	I-NP
adj 	adj 	 LS	I-NP
)  	)  	 -RRB-	I-NP
< 	< 	 SYM	O
0.001 	0.001 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
there  	there  	 EX	O
were  	were  	 VBD	O
no  	no  	 DT	O
differences  	differences  	 NNS	O
between  	between  	 IN	O
the  	the  	 DT	O
three  	three  	 CD	O
regional  	regional  	 JJ	B-NP
PWVs  	PWVs  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
two  	two  	 CD	O
groups  	groups  	 NNS	O
at  	at  	 IN	O
the  	the  	 DT	O
aorta-femoral 	aorta-femoral 	 JJ	B-NP
,  	,  	 ,	O
femoral-dorsalis 	femoral-dorsalis 	 NNP	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
aorta-radialis  	aorta-radialis  	 JJ	B-NP
arteries  	arteries  	 NNS	I-NP
( 	( 	 -LRB-	O
p 	p 	 FW	B-NP
( 	( 	 -LRB-	I-NP
adj 	adj 	 LS	I-NP
) 	) 	 -RRB-	O
> 	> 	 CD	O
0.05  	0.05  	 CD	O
for  	for  	 IN	O
all 	all 	 DT	O
) 	) 	 -RRB-	O
.  	.  	 .	O
FMS  	FMS  	 NNP	B-NP
subjects  	subjects  	 NNS	I-NP
had  	had  	 VBD	O
significantly  	significantly  	 RB	O
higher  	higher  	 RBR	O
serum  	serum  	 JJ	B-NP
IL-8  	IL-8  	 CD	I-NP
levels  	levels  	 NNS	I-NP
than  	than  	 IN	O
did  	did  	 VBD	O
the  	the  	 DT	O
healthy  	healthy  	 JJ	O
controls  	controls  	 NNS	O
( 	( 	 -LRB-	O
327.9±588.7  	327.9±588.7  	 FW	O
vs.  	vs.  	 FW	O
76.4±90.5 	76.4±90.5 	 FW	O
,  	,  	 ,	O
p 	p 	 NNS	B-NP
( 	( 	 -LRB-	I-NP
adj 	adj 	 LS	I-NP
) 	) 	 -RRB-	O
=0.041 	=0.041 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
there  	there  	 EX	O
were  	were  	 VBD	O
no  	no  	 DT	O
significant  	significant  	 JJ	O
differences  	differences  	 NNS	O
in  	in  	 IN	O
serum  	serum  	 CD	B-NP
IL-1β 	IL-1β 	 CD	I-NP
,  	,  	 ,	O
IL-6 	IL-6 	 NNP	B-NP
,  	,  	 ,	O
VEGF 	VEGF 	 NNP	B-NP
,  	,  	 ,	O
or  	or  	 CC	O
NOx  	NOx  	 JJ	B-NP
levels  	levels  	 NNS	I-NP
between  	between  	 IN	O
the  	the  	 DT	O
FMS  	FMS  	 NNP	B-NP
patients  	patients  	 NNS	O
and  	and  	 CC	O
the  	the  	 DT	O
controls  	controls  	 NNS	O
( 	( 	 -LRB-	O
p 	p 	 FW	B-NP
( 	( 	 -LRB-	I-NP
adj 	adj 	 LS	I-NP
) 	) 	 -RRB-	O
> 	> 	 CD	O
0.05  	0.05  	 CD	O
of  	of  	 IN	O
all 	all 	 DT	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Serum  	Serum  	 NNP	B-NP
IL-8  	IL-8  	 NNP	I-NP
level  	level  	 NN	I-NP
did  	did  	 VBD	O
not  	not  	 RB	O
correlate  	correlate  	 VBN	O
with  	with  	 IN	O
PWV  	PWV  	 NNP	B-NP
and  	and  	 CC	O
AIx  	AIx  	 JJ	O
in  	in  	 IN	O
FMS  	FMS  	 NNP	B-NP
patients 	patients 	 NNS	O
.  	.  	 .	O
This  	This  	 DT	O
study  	study  	 NN	O
demonstrates  	demonstrates  	 VBZ	O
higher  	higher  	 JJR	O
AIx  	AIx  	 JJ	O
and  	and  	 CC	O
IL-8  	IL-8  	 CD	B-NP
levels  	levels  	 NNS	I-NP
in  	in  	 IN	O
FMS  	FMS  	 NNP	B-NP
subjects  	subjects  	 VBZ	O
compared  	compared  	 VBN	O
to  	to  	 TO	O
those  	those  	 DT	O
of  	of  	 IN	O
the  	the  	 DT	O
controls 	controls 	 NNS	O
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
arterial  	arterial  	 JJ	B-NP
stiffness  	stiffness  	 NNS	I-NP
including  	including  	 VBG	O
AIx  	AIx  	 JJ	O
in  	in  	 IN	O
FMS  	FMS  	 NNP	B-NP
was  	was  	 VBD	O
not  	not  	 RB	O
determined  	determined  	 VBN	O
by  	by  	 IN	O
the  	the  	 DT	O
serum  	serum  	 JJ	B-NP
IL-8  	IL-8  	 CD	I-NP
level 	level 	 NN	I-NP
.  	.  	 .	O
